SAFETY AND EFFICACY OF REDUCED OR FULL DOSE OF CYCLOSPORINE (NEORAL®) IN COMBINATION WITH MYCOPHENOLATESODIUM (MYFORTIC®), BASILIXIMAB (SIMULECT®), AND STEROIDS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles